ADPT: Adaptive Biotechnologies Corporation Stocks News on September 18, 2025

IONS Up on FDA's Breakthrough Tag for ION582 in Angelman Syndrome

ADPT

Zacks

7 days ago

IONS Up on FDA's Breakthrough Tag for ION582 in Angelman Syndrome

SNY Down Despite Eczema Candidate Meeting Goal in Phase III Study

ADPT

Zacks

13 days ago

SNY Down Despite Eczema Candidate Meeting Goal in Phase III Study

PTC drug for Friedrich’s ataxia rejected; Lilly sells nearly $7B in bonds

ADPT

BioPharma Dive

a month ago

PTC drug for Friedrich’s ataxia rejected; Lilly sells nearly $7B in bonds

ADPT

MT Newswires

a month ago

Adaptive Biotechnologies Shares Fall After Genentech Collaboration Termination

ADPT

Zacks

3 months ago

Adaptive Biotechnologies (ADPT) Surges 12.5%: Is This an Indication of Further Gains?

ADPT

Insider Monkey

3 months ago

Craig-Hallum Initiates Coverage of Adaptive Biotechnologies (ADPT) stock, Gives Buy

Is Bio-Techne Stock Underperforming the Nasdaq?

ADPT

Barchart

3 months ago

Is Bio-Techne Stock Underperforming the Nasdaq?

ADPT

MT Newswires

3 months ago

Craig-Hallum Initiates Adaptive Biotechnologies at Buy With $15 Price Target

ADPT

Zacks

3 months ago

What Makes Adaptive Biotechnologies (ADPT) a New Buy Stock

ADPT

Zacks

3 months ago

Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year?

Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers

ADPT

GlobeNewswire

4 months ago

Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers

SPRO Stock Soars 245% on GSK-Partnered UTI Drug Meeting Study Goal

ADPT

Zacks

4 months ago

SPRO Stock Soars 245% on GSK-Partnered UTI Drug Meeting Study Goal

U.S. Govt. Cancels $766M Funding Contract for Moderna's Bird Flu Shot

ADPT

Zacks

4 months ago

U.S. Govt. Cancels $766M Funding Contract for Moderna's Bird Flu Shot

Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

ADPT

GlobeNewswire

4 months ago

Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

ADPT

Zacks

4 months ago

Is Adaptive Biotechnologies (ADPT) Outperforming Other Medical Stocks This Year?

BioMarin Offers to Buy Inozyme for $270M to Boost Enzyme Therapy Biz

ADPT

Zacks

4 months ago

BioMarin Offers to Buy Inozyme for $270M to Boost Enzyme Therapy Biz

AbbVie Secures FDA Nod for New ADC Drug Emrelis in Lung Cancer

ADPT

Zacks

4 months ago

AbbVie Secures FDA Nod for New ADC Drug Emrelis in Lung Cancer

Allogene's Q1 Earnings In Line With Estimates, Sales Nil

ADPT

Zacks

4 months ago

Allogene's Q1 Earnings In Line With Estimates, Sales Nil

ADPT

Zacks

4 months ago

Adaptive Biotechnologies (ADPT) is a Great Momentum Stock: Should You Buy?

NVAX Stock Gains 12% on Q1 Earnings & Sales Beat, '25 Sales View Up

ADPT

Zacks

4 months ago

NVAX Stock Gains 12% on Q1 Earnings & Sales Beat, '25 Sales View Up

ADPT

Zacks

4 months ago

Does Adaptive Biotechnologies (ADPT) Have the Potential to Rally 26.45% as Wall Street Analysts Expect?

ADPT

Zacks

4 months ago

Has Adaptive Biotechnologies (ADPT) Outpaced Other Medical Stocks This Year?

ADPT

MT Newswires

4 months ago

Adaptive Biotechnologies Insider Sold Shares Worth $502,828, According to a Recent SEC Filing

ADPT

Simply Wall St.

4 months ago

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$10.57

Adaptive Biotechnologies First Quarter 2025 Earnings: Beats Expectations

ADPT

Simply Wall St.

4 months ago

Adaptive Biotechnologies First Quarter 2025 Earnings: Beats Expectations

ADPT

MT Newswires

5 months ago

Sector Update: Health Care Stocks Higher Friday Afternoon

ADPT

MT Newswires

5 months ago

Adaptive Biotechnologies Shares Surge After Q1 Loss Narrows, Revenue Rises

ADPT

Thomson Reuters StreetEvents

5 months ago

Q1 2025 Adaptive Biotechnologies Corp Earnings Call

ADPT

GuruFocus.com

5 months ago

Adaptive Biotechnologies Corp (ADPT) Q1 2025 Earnings Call Highlights: Strong MRD Revenue ...

ADPT

Zacks

5 months ago

Adaptive Biotechnologies (ADPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

ADPT

Zacks

5 months ago

Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Tops Revenue Estimates

ADPT

Associated Press Finance

5 months ago

Adaptive Biotechnologies: Q1 Earnings Snapshot

Adaptive Biotechnologies Reports First Quarter 2025 Financial Results

ADPT

GlobeNewswire

5 months ago

Adaptive Biotechnologies Reports First Quarter 2025 Financial Results

OpenAI And Andreessen Horowitz Lead $43M Round For Cybersecurity Startup Taking On AI Scammers, Deepfakes, And Voice Spoofs

ADPT

Benzinga

5 months ago

OpenAI And Andreessen Horowitz Lead $43M Round For Cybersecurity Startup Taking On AI Scammers, Deepfakes, And Voice Spoofs

Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025

ADPT

GlobeNewswire

5 months ago

Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025

ADPT

MT Newswires

5 months ago

Adaptive Biotechnologies' Mantle Cell Lymphoma Test Receives Expanded Medicare Coverage

Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell Lymphoma

ADPT

GlobeNewswire

5 months ago

Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell Lymphoma

ADPT

MT Newswires

6 months ago

Adaptive Biotechnologies Gains Following Goldman Sachs Upgrade, Share Climb 6% Near Friday Close

ADPT

MT Newswires

6 months ago

Goldman Sachs Upgrades Adaptive Biotechnologies to Buy From Neutral, Adjusts Price Target to $9 From $8

ADPT

Insider Monkey

6 months ago

Adaptive Biotechnologies (ADPT): Among Stocks Insiders Are Selling In March

Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma

ADPT

GlobeNewswire

6 months ago

Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma

ADPT

MT Newswires

6 months ago

Adaptive Biotechnologies Insider Sold Shares Worth $1,600,417, According to a Recent SEC Filing

ADPT

MT Newswires

7 months ago

Adaptive Biotechnologies Insider Sold Shares Worth $2,410,700, According to a Recent SEC Filing

ADPT

MT Newswires

7 months ago

Adaptive Biotechnologies Insider Sold Shares Worth $3,985,754, According to a Recent SEC Filing

Adaptive Biotechnologies price target raised to $12 from $10 at Scotiabank

ADPT

TipRanks

7 months ago

Adaptive Biotechnologies price target raised to $12 from $10 at Scotiabank

Adaptive Biotechnologies Full Year 2024 Earnings: EPS Beats Expectations

ADPT

Simply Wall St.

7 months ago

Adaptive Biotechnologies Full Year 2024 Earnings: EPS Beats Expectations

ADPT

Zacks

7 months ago

Adaptive Biotechnologies (ADPT) Moves to Buy: Rationale Behind the Upgrade

ADPT

Thomson Reuters StreetEvents

7 months ago

Q4 2024 Adaptive Biotechnologies Corp Earnings Call

ADPT

Zacks

7 months ago

Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year?

ADPT

GuruFocus.com

7 months ago

Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings Call Highlights: Strong MRD Revenue ...

ADPT

Zacks

7 months ago

Adaptive Biotechnologies (ADPT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

ADPT

Zacks

7 months ago

Adaptive Biotechnologies (ADPT) Reports Q4 Loss, Tops Revenue Estimates

ADPT

MT Newswires

7 months ago

Adaptive Biotechnologies' Q4 Loss Narrows, Revenue Rises

ADPT

Associated Press Finance

7 months ago

Adaptive Biotechnologies: Q4 Earnings Snapshot

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results

ADPT

GlobeNewswire

7 months ago

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results

ADPT

GuruFocus.com

7 months ago

Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings Report Preview: What To Look For

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

ADPT

GlobeNewswire

7 months ago

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

PhaseV and Alimentiv to support execution of adaptive clinical trials for GI

ADPT

Clinical Trials Arena

7 months ago

PhaseV and Alimentiv to support execution of adaptive clinical trials for GI

ADPT

Simply Wall St.

8 months ago

The 5.4% return this week takes Adaptive Biotechnologies' (NASDAQ:ADPT) shareholders one-year gains to 99%

ADPT

Insider Monkey

8 months ago

Why Adaptive Biotechnologies Corporation (ADPT) Is Skyrocketing Now

ADPT

Insider Monkey

8 months ago

Why Is Andreas Halvorsen Bullish On Adaptive Biotechnologies Corporation (ADPT) Now?

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025

ADPT

GlobeNewswire

8 months ago

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025

ADPT

Zacks

8 months ago

Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year?

ADPT

Zacks

8 months ago

Adaptive Biotechnologies (ADPT) Soars 18.0%: Is Further Upside Left in the Stock?

ADPT

MT Newswires

8 months ago

Adaptive Biotechnologies, NeoGenomics to Support Minimal Residual Disease Monitoring Options for Blood Cancer Patients

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients

ADPT

GlobeNewswire

8 months ago

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients

Adaptive Biotechnologies Announces Clinical Lab Fee Schedule Rate of $2,007 for clonoSEQ® Test for Minimal Residual Disease Assessment is Effective as of January 1st, 2025

ADPT

GlobeNewswire

8 months ago

Adaptive Biotechnologies Announces Clinical Lab Fee Schedule Rate of $2,007 for clonoSEQ® Test for Minimal Residual Disease Assessment is Effective as of January 1st, 2025

Adaptive Biotechnologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference

ADPT

GlobeNewswire

8 months ago

Adaptive Biotechnologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?

ADPT

Zacks

9 months ago

Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?

Are Medical Stocks Lagging BellRing Brands (BRBR) This Year?

ADPT

Zacks

9 months ago

Are Medical Stocks Lagging BellRing Brands (BRBR) This Year?

Adaptive unveils data of MRD assessment test in blood cancer treatment

ADPT

Medical Device Network

9 months ago

Adaptive unveils data of MRD assessment test in blood cancer treatment

Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions

ADPT

GlobeNewswire

9 months ago

Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions

Adaptive Research and WRO to expand cancer trial access in San Francisco Bay Area

ADPT

Clinical Trials Arena

9 months ago

Adaptive Research and WRO to expand cancer trial access in San Francisco Bay Area

Adaptive Biotechnologies Announces Over 65 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 66th ASH Annual Meeting

ADPT

GlobeNewswire

9 months ago

Adaptive Biotechnologies Announces Over 65 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 66th ASH Annual Meeting

ADPT

Zacks

10 months ago

Is Adaptive Biotechnologies (ADPT) Outperforming Other Medical Stocks This Year?

Novotech report notes shift to adaptive designs in clinical trials

ADPT

Clinical Trials Arena

10 months ago

Novotech report notes shift to adaptive designs in clinical trials

ADPT

Zacks

10 months ago

Wall Street Analysts Predict a 31.36% Upside in Adaptive Biotechnologies (ADPT): Here's What You Should Know

Is Cardinal Health (CAH) Outperforming Other Medical Stocks This Year?

ADPT

Zacks

10 months ago

Is Cardinal Health (CAH) Outperforming Other Medical Stocks This Year?

Adaptive Biotechnologies Third Quarter 2024 Earnings: Beats Expectations

ADPT

Simply Wall St.

10 months ago

Adaptive Biotechnologies Third Quarter 2024 Earnings: Beats Expectations

ADPT

Thomson Reuters StreetEvents

10 months ago

Q3 2024 Adaptive Biotechnologies Corp Earnings Call

ADPT

GuruFocus.com

10 months ago

Adaptive Biotechnologies Corp (ADPT) Q3 2024 Earnings Call Highlights: Strong MRD Growth Amidst ...

ADPT

Zacks

10 months ago

Adaptive Biotechnologies (ADPT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

ADPT

Zacks

10 months ago

Adaptive Biotechnologies (ADPT) Reports Q3 Loss, Tops Revenue Estimates

ADPT

Associated Press Finance

10 months ago

Adaptive Biotechnologies: Q3 Earnings Snapshot

Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results

ADPT

GlobeNewswire

10 months ago

Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results

Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell Lymphoma

ADPT

GlobeNewswire

10 months ago

Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell Lymphoma

ADPT

GuruFocus.com

10 months ago

Earnings To Watch: Adaptive Biotechnologies Corp (ADPT) Reports Q3 2024 Result

November 2024's Top US Penny Stocks With Growth Potential

ADPT

Simply Wall St.

a year ago

November 2024's Top US Penny Stocks With Growth Potential

Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024

ADPT

GlobeNewswire

a year ago

Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024

Is Teva Pharmaceutical Industries (TEVA) Stock Outpacing Its Medical Peers This Year?

ADPT

Zacks

a year ago

Is Teva Pharmaceutical Industries (TEVA) Stock Outpacing Its Medical Peers This Year?

Parametric company Adaptive Insurance launches operations

ADPT

Life Insurance International

a year ago

Parametric company Adaptive Insurance launches operations

ADPT

MT Newswires

a year ago

Adaptive Biotechnologies Receives IVDR Certification for clonoSEQ

Adaptive Announces IVDR Certification for clonoSEQ® in European Union

ADPT

GlobeNewswire

a year ago

Adaptive Announces IVDR Certification for clonoSEQ® in European Union

Adaptive Biotechnologies to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

ADPT

GlobeNewswire

a year ago

Adaptive Biotechnologies to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

ADPT

Zacks

a year ago

Adaptive Biotechnologies (ADPT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

ADPT

Zacks

a year ago

Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates

ADPT

Associated Press Finance

a year ago

Adaptive Biotechnologies: Q2 Earnings Snapshot

Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results

ADPT

GlobeNewswire

a year ago

Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results

ADPT

Simply Wall St.

a year ago

Strong week for Adaptive Biotechnologies (NASDAQ:ADPT) shareholders doesn't alleviate pain of three-year loss

Adaptive builds automation tools to speed up construction payments

ADPT

TechCrunch

a year ago

Latest Adaptive Biotechnologies Corporation (ADPT) News on September 18, 2025

Share on Social Networks: